Showing results (81-90 of 114) with videos related to
Sort By:
Pageof 12
Journal of Clinical Pharmacology|January 1, 1977
Changes in the fasting blood sugar after hydrochlorothiazide and potassium supplementationK F McFarland, A A CarrJournal of the National Medical Association|March 4, 1999
Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacksL M Prisant, J M Neutel, K Ferdinand, et al.The American Journal of Cardiology|August 15, 1996
Efficacy and tolerability of lovastatin in 459 African-Americans with hypercholesterolemiaL M Prisant, M Downton, L O Watkins, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|June 10, 2004
Mortality in patients with microvascular diseaseDavid S Marks, Surrendra Gudapati, L M Prisant, et al.Hypertension (Dallas, Tex. : 1979)|April 1, 1993
National standard for measurement of resting and ambulatory blood pressures with automated sphygmomanometersW B White, A S Berson, C Robbins, et al.American Journal of Hypertension|September 1, 1996
Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapyM R Weir, L M Prisant, V Papademetriou, et al.American Journal of Hypertension|February 1, 1995
American National Standard for nonautomated sphygmomanometers. Summary reportL M Prisant, B S Alpert, C B Robbins, et al.Journal of Cardiovascular Pharmacology|December 1, 1990
Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalolT Li, A A Carr, R C DageMagnetic Resonance Imaging|January 1, 1993
Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiographyJ D Allison, F W Flickinger, J C Wright, et al.Journal of Clinical Pharmacology|March 1, 1991
Mexiletine versus quinidine as first-line antiarrhythmia therapy: results from consecutive trialsM J Frank, L O Watkins, L M Prisant, et al.Pageof 12